Why the study?
Does carteolol compared to atenolol improve vascular resistance and flow in patients with essential hypertension?
Does carteolol compared to atenolol improve vascular resistance and flow in patients with essential hypertension?
Carteolol, a nonselective beta-blocker, induces arteriolar dilation compared to the constriction seen with the selective beta-blocker atenolol in hypertensive patients.
Answers are grounded in this paper and cite their sources.
Carteolol was associated with favorable vascular parameters versus atenolol in hypertension; hypothesis-generating and should not yet change practice.
The long-term effects of selective (atenolol) and nonselective (carteolol) beta-blockers on brachial artery diameter velocity and flow and on vascular resistance (pulsed Doppler) were compared in two groups of 10 hypertensive patients at respective daily doses of 100 and 20 mg. The drugs decreased mean blood pressure (p less than 0.01) with similar magnitude, although systolic blood pressure was decreased more by atenolol than by carteolol (p less than 0.05). Heart rate was decreased by atenolol (p less than 0.01) but was unchanged by carteolol. The drugs did not change brachial circulation when the hand circulation was present. During hand exclusion (wrist occlusion) comparison from baseline showed that atenolol decreased velocity and flow (p less than 0.01, p less than 0.05) and increased resistance (p less than 0.05), whereas carteolol decreased resistance (p less than 0.05); after 3 months of treatment, velocity and flow were higher (p less than 0.01, p less than 0.001) and resistance was lower (p less than 0.01) with carteolol than with atenolol. Thus, hand exclusion demonstrated opposite drug effects on arterioles--dilation for carteolol and constriction for atenolol.
No takes yet. Share an insight, caveat, or question.
Merli et al. (1989) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: